Denileukin diftitox Completed Phase 2 Trials for Graft Versus Host Disease (cGvHD) / Immune System Disorders Treatment

Back to Denileukin diftitox

Indications	Status	Purpose	Phase
DBCOND0118738 (Graft Versus Host Disease (cGvHD)) DBCOND0033236 (Immune System Disorders)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00224874	Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)	Denileukin diftitox (DB00004) Etanercept (DB00005) Mycophenolate mofetil (DB00688) Pentostatin (DB00552)